"Sanatorio Juan XXIII"

During the past decade, Sanatorio Juan XXIII conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sanatorio Juan XXIII" are "Influenza A" (2 trials), "Epidemiology" (1 trials), "Respiration, Artificial" (1 trials) and "Respiratory Syncytial Virus Infections" (1 trials). Many other conditions were trialed in "Sanatorio Juan XXIII" in a lesser frequency.

Most popular intervention types in "Sanatorio Juan XXIII" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials), "JNJ-53718678 500 mg" (1 trials) and "JNJ-53718678 80 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio Juan XXIII" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Sanatorio Juan XXIII". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sanatorio Juan XXIII, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio Juan XXIII, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".